Business Wire

Beating The Risks of Expanding Into Emerging Market IT Channels

17.3.2025 08:00:00 CET | Business Wire | Press Release

Share

For IT vendors, emerging markets are risky. Local regulations, cultural differences, local currencies, channel liquidity, and settling disputes complicate such plans. Fortunately, a new generation of channel finance solutions is smoothing the journey.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250314300371/en/

Boris Todorov, Executive Vice President of WeFi's Client Solutions Group

The emerging market growth trend

Emerging markets are becoming the engines powering global and regional trade, growing at an annual rate of 4.2% (IMF), versus 1.7% in mature economies, and contributing two-thirds to global growth.

India's heavy investments in its technology sector, China's focus on modern healthcare, Brazil's ambitions for green energy, and the rise of mobility among African countries—digital technology enables strong growth in emerging markets. Technology vendors are changing how they tap into those markets through supporting local IT channels.

"For decades, technology was sold through various hubs around the world, and the channel effectively stopped there," says Boris Todorov, Executive Vice President of WeFi's Client Solutions Group. "But what we have seen is that IT vendors have established onshore presence in several countries with the goal of developing local channel programmes."

Emerging Market Blues

However, establishing presences in emerging markets is hard, expensive, and risky to local complexities.

"Emerging markets bring several challenges, starting with import regulations, taxes, local currency risks including convertibility, legal risks, banking regulation, compliance, and credit risk. All of the listed areas are subject to changes, which can impact the other areas; hence the complexities and resources required," says Todorov.

Vendor channel programmes must accommodate and manage challenges like credit checks, legal agreements, currency fluctuations, negotiations around delivery and receivables, and disputes to reap expansion rewards. Yet, traditional channel finance companies often lack the scope or flexibility to help.

How Channel Finance Derisks Emerging Markets

A new generation of channel finance fintechs are filling this gap. For example, WeFi develops managed vendor channel programs that include legal contracts, easy access to credit, local currency management, buyer vetting, receivables forecasting, and even ensuring vendor customers have the connectivity to access these services.

"We address the issues inherent to different channel finance situations so that sellers and buyers can focus on their pure business," says Todorov. "Emerging market resellers are excited to join these managed channel programs because they can access longer terms and higher credit limits that can be calibrated with minimal usage of insurance or reseller collateral. Vendors and creditors vastly simplify their administration and oversight. For example, treasurers can use our platform data to predict future demand and potential payment delays accurately."

They combine human expertise supported by proprietary technologies such as WeFi's IZZI platform. These specialised platforms deliver innovative solutions that streamline channel finance processes, introduce new finance technologies, and facilitate complex deals and programs.

"In 2024, we have seen and financed a number of large-AI related deals, which have been split between developed and emerging markets, and which require longer terms, specific credit lines and structures which often take risk on the final customer," says Todorov. "The shift from traditional channel finance is continuing. Channel finance solution providers stay on top of these trends by working closely with their clients who require customised structured solutions."

END

For more information about WeFi Technology Group visit: https://wefitec.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20250314300371/en/

Contacts

Media: Victoria Lindsay | victoria@innocomm.co.za

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye